Search Results - Alkabbani W
- Showing 1 - 1 results of 1
-
1
Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date by Alkabbani W, Gamble JM
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book